Aurum Health Research Limited Report issue

Foundation Phase 2

Organization Overview

First Clinical Trial
2005
NCT00125970
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Aurum Biosciences Ltd

Active Ingredients

Drugs in Phase 2 Trials (4)

perfluorocarbon (1 trial)

sodium chloride (1 trial)

vrchivadv014-00-vp (1 trial)

vrc-hivdna-016-00-vp (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

HIV Infections (Phase 2)

Stroke (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 2
  • # of Trial APIs: 4